We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
110 hedge funds and large institutions have $76.6M invested in Cardiff Oncology in 2025 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
632% more call options, than puts
Call options by funds: $2.08M | Put options by funds: $284K
47% more capital invested
Capital invested by funds: $52.1M → $76.6M (+$24.4M)
2.56% more ownership
Funds ownership: 37.89% → 40.45% (+2.6%)
6% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 18
2% less funds holding
Funds holding: 112 → 110 (-2)
21% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 33
Holders
110
Holders Change
-2
Holders Change %
-1.79%
% of All Funds
1.34%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
17
Increased
26
Reduced
33
Closed
18
Calls
$2.08M
Puts
$284K
Net Calls
+$1.79M
Net Calls Change
+$61K
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$2.8M |
| 2 |
Two Sigma Investments
New York
|
+$1.21M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$800K |
| 4 |
Two Sigma Advisers
New York
|
+$777K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$490K |
